Betaine (TMG).

Homocysteine is remethylated to methionine either by methionine synthase using 5-methyltetrahydrofolate or by betaine homocysteine methyltransferase using betaine. Supplying both gives the cell either route rather than loading one.

Methionine synthase needs cobalamin as its cofactor, while the betaine route runs without B12 entirely. Pairing them covers the folate and B12 dependent step and its backup at the same time.

Homocysteine leaves the cycle through cystathionine beta-synthase and cystathionine gamma-lyase, both pyridoxal phosphate enzymes, while betaine returns it to methionine. One partner recycles and the other clears, so together they cover both exits.

Betaine is made in the body by two-step oxidation of choline in liver and kidney mitochondria. Supplying betaine directly leaves more choline available for phosphatidylcholine and acetylcholine synthesis instead of being consumed as a methyl source.

Betaine regenerates methionine, and methionine is adenosylated to form S-adenosylmethionine, the donor for most cellular methylation reactions. Betaine feeds the pool that SAM-e is drawn from.

The betaine homocysteine methyltransferase reaction transfers one methyl group from betaine to homocysteine, producing methionine and dimethylglycine. The two sit on opposite sides of the same enzymatic step.

After donating a methyl group betaine becomes dimethylglycine, which is demethylated further to sarcosine and then to glycine, feeding one-carbon units into the folate pool along the way. Betaine and glycine are the two ends of that same chain.

The final step of creatine synthesis uses S-adenosylmethionine as its methyl donor and accounts for a large share of whole-body methylation demand. Supplying creatine directly lowers that demand while betaine replenishes the methyl supply, and both also act as cellular osmolytes in muscle.

Methylenetetrahydrofolate reductase depends on FAD derived from riboflavin to generate the 5-methyl folate used by the folate route. When that branch runs slowly the betaine route carries more of the load, so the two are complementary.

Betaine homocysteine methyltransferase holds a catalytic zinc that activates the homocysteine thiol for methyl transfer. Without adequate zinc the betaine route cannot run at full rate.

Serine donates a one-carbon unit to tetrahydrofolate via SHMT, generating glycine and 5,10-methylene-THF. Betaine's route to methionine is folate-independent, and the glycine it liberates through the dimethylglycine to sarcosine steps is interconvertible with serine. The two feed the same methyl economy from separate entry points.

Homocysteine has two exits: remethylation back to methionine, which betaine drives, or transsulfuration to cystathionine and then cysteine. N-acetylcysteine supplies cysteine directly, which reduces the demand for that catabolic exit. Whether the pairing shifts partitioning in either direction in a person is not something the betaine literature settles.

Cystathionine beta-synthase commits homocysteine to cysteine, the rate-limiting substrate for glutathione. Betaine acts on the other branch by pushing homocysteine back to methionine. A formula carrying both is supporting two competing exits from the same intermediate, which is a description of the pathway rather than a claimed benefit.

Cysteine oxidation leads to hypotaurine and then taurine, so taurine sits at the end of the branch betaine's substrate can take. Both betaine and taurine also function as organic osmolytes that cells accumulate to hold volume without disturbing protein function. Two separate relationships, both established biochemistry, neither a measured combined effect.

Sulfur carbon from cysteine catabolism passes through sulfite before reaching sulfate, and sulfite oxidase requires a molybdenum cofactor. Betaine's methyl donation determines how much homocysteine takes the remethylation route rather than the sulfur-disposal route. Molybdenum is a requirement on the disposal side, not something betaine changes.

Excess nicotinamide is cleared by methylation to N1-methylnicotinamide, and that reaction uses SAM as the methyl donor. High nicotinamide intake therefore draws on the same methyl pool betaine helps replenish. This is the textbook reason methyl donors are discussed alongside high-dose niacinamide, and it is a demand relationship rather than a benefit claim.

NAD precursors are ultimately degraded through nicotinamide, whose disposal route is SAM-dependent methylation. Raising precursor intake raises that methyl demand. Betaine feeds methionine and therefore SAM regeneration by a folate-independent route, which is why the two are often discussed together, though the pairing has not been measured in the betaine literature here.

Nicotinamide mononucleotide enters the same NAD salvage cycle and its nicotinamide is cleared by SAM-dependent methylation. Higher throughput means more methyl groups spent. The relationship is about methyl-group budgeting, not about betaine changing NAD levels.

Choline released from phosphatidylcholine is oxidised in mitochondria by choline dehydrogenase and betaine aldehyde dehydrogenase to give betaine. Supplemental betaine spares choline from that oxidative fate, leaving more available for phospholipid and acetylcholine synthesis. The relationship runs both ways along one pathway.

Lecithin supplies phosphatidylcholine, which yields choline, which is irreversibly oxidised to betaine in liver and kidney mitochondria. Because that oxidation cannot be run backwards, betaine and choline are not interchangeable in both directions. A formula with both covers the phospholipid role and the methyl-donor role separately.

Betaine, inositol, taurine and glycerophosphocholine are the main organic osmolytes mammalian cells use, and their transporters are upregulated together under hypertonic stress. Betaine transport into cells runs on the BGT1 transporter. Sharing a physiological role is not the same as a demonstrated joint effect, so this stays a mechanism note.

Extracellular sodium and chloride set the osmotic pressure cells face, and organic osmolytes including betaine are what cells accumulate internally in response. That is the rationale behind putting betaine into hydration products. The physiology is settled; that a given dose changes hydration measures in people is not something the candidate literature here shows.

A randomised trial of a multi-ingredient pre-workout product containing betaine reported lean mass, performance and biomarker measures. Because the product carried several actives together, the betaine contribution cannot be separated from beta-alanine or the rest of the blend. It does document that the two are used together in a studied formula.

Caffeine and betaine appear together in pre-workout blends, and the randomised trial of one such product reported performance and body composition measures for the blend as a whole. No part of that result is attributable to betaine alone. Caffeine is also a mild diuretic, which is worth noting next to an osmolyte.

Homocysteine is produced from methionine in dietary protein, so a high-protein intake raises the flux the remethylation and transsulfuration routes have to handle. Betaine drives one of those routes. The relationship is about substrate load, and it explains why methyl-donor content is discussed in high-protein regimens.

Gut microbial enzymes cleave trimethylamine from betaine, carnitine and choline, and the liver then oxidises it to trimethylamine N-oxide. Taking both raises the total substrate for that route. This is a flag about a shared microbial fate, not a claim about what the resulting metabolite does.

Betaine hydrochloride dissociates to the betaine cation and hydrochloric acid, and it appears in digestive formulas for the acid rather than for the methyl group. Anhydrous betaine and betaine hydrochloride therefore both deliver betaine but are chosen for different reasons. A label carrying both is delivering more total betaine than either line suggests on its own.